Paclitaxel- versus zotarolimus-eluting stents in diffuse coronary artery disease; 3-year clinical cutcomes

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 4 - Impact of stent design on post PCI outcomes PCI / stents: devices and technique ESC Premium Access ESC Congress 2016

ESC 365 is supported by

ESC 365 is supported by